Skip to main content
. 2017 Sep 15;28(9):1056–1061. doi: 10.1097/CAD.0000000000000540

Fig. 3.

Fig. 3

Epidermal growth factor receptor mutations were identified using the Scorpions-amplification refractory mutation system method in peripheral blood after progression on gefitinib therapy: (a) epidermal growth factor receptor 19 deletion detected. (b) T790M point mutation detected.